ADAMTS13 Improves Endothelial Function and Reduces Inflammation in Diabetic Retinopathy
The protease, a disintegrin and metalloproteinase with thrombospondin type 1 motif member 13 (ADAMTS13), known to cleave only the von Willebrand factor (VWF), has powerful regulatory effects on microvascular platelet adhesion, thrombosis, inflammation, and endothelial dysfunction. We study the prote...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/2/85 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832588834012921856 |
|---|---|
| author | Ahmed M. Abu El-Asrar Mohd I. Nawaz Ajmal Ahmad Mairaj Siddiquei Eef Allegaert Lowie Adyns Lotte Vanbrabant Priscilla W. Gikandi Gert De Hertogh Sofie Struyf Ghislain Opdenakker |
| author_facet | Ahmed M. Abu El-Asrar Mohd I. Nawaz Ajmal Ahmad Mairaj Siddiquei Eef Allegaert Lowie Adyns Lotte Vanbrabant Priscilla W. Gikandi Gert De Hertogh Sofie Struyf Ghislain Opdenakker |
| author_sort | Ahmed M. Abu El-Asrar |
| collection | DOAJ |
| description | The protease, a disintegrin and metalloproteinase with thrombospondin type 1 motif member 13 (ADAMTS13), known to cleave only the von Willebrand factor (VWF), has powerful regulatory effects on microvascular platelet adhesion, thrombosis, inflammation, and endothelial dysfunction. We study the protection against diabetes-induced retinal injury in experimental rats by supplementation with recombinant ADAMTS13. We compare human epiretinal membranes and vitreous samples from nondiabetic subjects and patients with proliferative diabetic retinopathy (PDR) and extend in vitro analyses with the use of various immunodetection and spectrofluorimetric methods on rat retina and human retinal glial and endothelial cell cultures. Functional studies include the assessment of the blood–retinal barrier (BRB), cell adhesion, and in vitro angiogenesis. In epiretinal membranes, endothelial cells and monocytes/macrophages express ADAMTS13. The levels of VWF, the platelet marker CD41, ADAMTS13, and the biomarkers of endothelial cell injury soluble VE-cadherin and soluble syndecan-1 are increased in PDR vitreous. ADAMTS13 is downregulated in diabetic rat retinas. The intravitreal administration of ADAMTS13 attenuates diabetes-induced BRB breakdown, the downregulation of VE-cadherin and β-catenin, and the upregulation of VWF, CD41, phospho-ERK1/2, HMGB1, VCAM-1, and ICAM-1. In Müller cells, ADAMTS13 attenuates MCP-1, MMP-9, and ROS upregulation induced by diabetic mimetic conditions. In HRMECs, ADAMTS13 attenuates the shedding of the soluble VE-cadherin and soluble syndecan-1 and the levels of phospho-ERK1/2, MCP-1, fractalkine, and ROS induced by diabetic mimetic conditions, the upregulation of ICAM-1 and VCAM-1 elicited by TNF-α, the adherence of monocytes induced by TNF-α, and VEGF-induced migration of human retinal microvascular endothelial cells. Our findings suggest that enhancing ADAMTS13 levels in situ ameliorates diabetes-induced retinal inflammation and vascular dysfunction. |
| format | Article |
| id | doaj-art-4abbda263a4e4c33bfc4c52e808c615b |
| institution | Kabale University |
| issn | 2073-4409 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cells |
| spelling | doaj-art-4abbda263a4e4c33bfc4c52e808c615b2025-01-24T13:26:37ZengMDPI AGCells2073-44092025-01-011428510.3390/cells14020085ADAMTS13 Improves Endothelial Function and Reduces Inflammation in Diabetic RetinopathyAhmed M. Abu El-Asrar0Mohd I. Nawaz1Ajmal Ahmad2Mairaj Siddiquei3Eef Allegaert4Lowie Adyns5Lotte Vanbrabant6Priscilla W. Gikandi7Gert De Hertogh8Sofie Struyf9Ghislain Opdenakker10Department of Ophthalmology, College of Medicine, King Saud University, Riyadh 11411, Saudi ArabiaDepartment of Ophthalmology, College of Medicine, King Saud University, Riyadh 11411, Saudi ArabiaDepartment of Ophthalmology, College of Medicine, King Saud University, Riyadh 11411, Saudi ArabiaDepartment of Ophthalmology, College of Medicine, King Saud University, Riyadh 11411, Saudi ArabiaLaboratory of Histochemistry and Cytochemistry, University of Leuven, 3000 Leuven, BelgiumLaboratory of Molecular Immunology, Department of Microbiology, Immunology and Transplantation, Rega Institute, University of Leuven, 3000 Leuven, BelgiumLaboratory of Molecular Immunology, Department of Microbiology, Immunology and Transplantation, Rega Institute, University of Leuven, 3000 Leuven, BelgiumDepartment of Ophthalmology, College of Medicine, King Saud University, Riyadh 11411, Saudi ArabiaLaboratory of Histochemistry and Cytochemistry, University of Leuven, 3000 Leuven, BelgiumLaboratory of Molecular Immunology, Department of Microbiology, Immunology and Transplantation, Rega Institute, University of Leuven, 3000 Leuven, BelgiumDepartment of Ophthalmology, College of Medicine, King Saud University, Riyadh 11411, Saudi ArabiaThe protease, a disintegrin and metalloproteinase with thrombospondin type 1 motif member 13 (ADAMTS13), known to cleave only the von Willebrand factor (VWF), has powerful regulatory effects on microvascular platelet adhesion, thrombosis, inflammation, and endothelial dysfunction. We study the protection against diabetes-induced retinal injury in experimental rats by supplementation with recombinant ADAMTS13. We compare human epiretinal membranes and vitreous samples from nondiabetic subjects and patients with proliferative diabetic retinopathy (PDR) and extend in vitro analyses with the use of various immunodetection and spectrofluorimetric methods on rat retina and human retinal glial and endothelial cell cultures. Functional studies include the assessment of the blood–retinal barrier (BRB), cell adhesion, and in vitro angiogenesis. In epiretinal membranes, endothelial cells and monocytes/macrophages express ADAMTS13. The levels of VWF, the platelet marker CD41, ADAMTS13, and the biomarkers of endothelial cell injury soluble VE-cadherin and soluble syndecan-1 are increased in PDR vitreous. ADAMTS13 is downregulated in diabetic rat retinas. The intravitreal administration of ADAMTS13 attenuates diabetes-induced BRB breakdown, the downregulation of VE-cadherin and β-catenin, and the upregulation of VWF, CD41, phospho-ERK1/2, HMGB1, VCAM-1, and ICAM-1. In Müller cells, ADAMTS13 attenuates MCP-1, MMP-9, and ROS upregulation induced by diabetic mimetic conditions. In HRMECs, ADAMTS13 attenuates the shedding of the soluble VE-cadherin and soluble syndecan-1 and the levels of phospho-ERK1/2, MCP-1, fractalkine, and ROS induced by diabetic mimetic conditions, the upregulation of ICAM-1 and VCAM-1 elicited by TNF-α, the adherence of monocytes induced by TNF-α, and VEGF-induced migration of human retinal microvascular endothelial cells. Our findings suggest that enhancing ADAMTS13 levels in situ ameliorates diabetes-induced retinal inflammation and vascular dysfunction.https://www.mdpi.com/2073-4409/14/2/85diabetic retinopathyADAMTS13inflammationblood–retinal barrier |
| spellingShingle | Ahmed M. Abu El-Asrar Mohd I. Nawaz Ajmal Ahmad Mairaj Siddiquei Eef Allegaert Lowie Adyns Lotte Vanbrabant Priscilla W. Gikandi Gert De Hertogh Sofie Struyf Ghislain Opdenakker ADAMTS13 Improves Endothelial Function and Reduces Inflammation in Diabetic Retinopathy Cells diabetic retinopathy ADAMTS13 inflammation blood–retinal barrier |
| title | ADAMTS13 Improves Endothelial Function and Reduces Inflammation in Diabetic Retinopathy |
| title_full | ADAMTS13 Improves Endothelial Function and Reduces Inflammation in Diabetic Retinopathy |
| title_fullStr | ADAMTS13 Improves Endothelial Function and Reduces Inflammation in Diabetic Retinopathy |
| title_full_unstemmed | ADAMTS13 Improves Endothelial Function and Reduces Inflammation in Diabetic Retinopathy |
| title_short | ADAMTS13 Improves Endothelial Function and Reduces Inflammation in Diabetic Retinopathy |
| title_sort | adamts13 improves endothelial function and reduces inflammation in diabetic retinopathy |
| topic | diabetic retinopathy ADAMTS13 inflammation blood–retinal barrier |
| url | https://www.mdpi.com/2073-4409/14/2/85 |
| work_keys_str_mv | AT ahmedmabuelasrar adamts13improvesendothelialfunctionandreducesinflammationindiabeticretinopathy AT mohdinawaz adamts13improvesendothelialfunctionandreducesinflammationindiabeticretinopathy AT ajmalahmad adamts13improvesendothelialfunctionandreducesinflammationindiabeticretinopathy AT mairajsiddiquei adamts13improvesendothelialfunctionandreducesinflammationindiabeticretinopathy AT eefallegaert adamts13improvesendothelialfunctionandreducesinflammationindiabeticretinopathy AT lowieadyns adamts13improvesendothelialfunctionandreducesinflammationindiabeticretinopathy AT lottevanbrabant adamts13improvesendothelialfunctionandreducesinflammationindiabeticretinopathy AT priscillawgikandi adamts13improvesendothelialfunctionandreducesinflammationindiabeticretinopathy AT gertdehertogh adamts13improvesendothelialfunctionandreducesinflammationindiabeticretinopathy AT sofiestruyf adamts13improvesendothelialfunctionandreducesinflammationindiabeticretinopathy AT ghislainopdenakker adamts13improvesendothelialfunctionandreducesinflammationindiabeticretinopathy |